Jing Wang

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 22

Top Topics

High Fat Diet Induced

Positron Emission Tomography

Clinical Evaluation

Top Venues

Molecular pharmaceutics

European journal of nuclear medicine and molecular imaging

Contrast media & molecular imaging

This page only lists publications with an associated author ORCID identifier.

Publications

Mingru Zhang, Fei Kang, Tong Xing, Junling Wang, Taoqi Ma, Guiyu Li, Zhiyong Quan, Weidong Yang, Xiaoyuan Chen, Jing Wang
First-in-human validation of enzymolysis clearance strategy for decreasing renal radioactivity using modified [ 68 Ga]Ga-HER2 Affibody. European journal of nuclear medicine and molecular imaging (2024)
Mingru Zhang, Fei Kang, Tong Xing, Junling Wang, Taoqi Ma, Guiyu Li, Zhiyong Quan, Weidong Yang, Xiaoyuan Chen, Jing Wang
First-in-human validation of enzymolysis clearance strategy for decreasing renal radioactivity using modified [ 68 Ga]Ga-HER2 Affibody. European journal of nuclear medicine and molecular imaging 51 (6) (2024)
Cheng Zhou, Guoquan Li, Zhiyong Quan, Zongke Deng, Guiyu Li, Mingru Zhang, Fei Kang, Weidong Yang, Jing Wang
Prospective Study Comparing [ 99m Tc]Tc-DP-FAPI Quantitative SPECT/CT with [ 68 Ga]Ga-FAPI-04 PET/CT in Patients with Gastrointestinal Tumors. Molecular pharmaceutics (2024)
Xiang Li, Xiaohui Lv, Zhiyong Quan, Tingting Han, Yongqiang Tang, Ying Liu, Mengxin Wang, Guiyu Li, Jiajun Ye, Jingyi Wang, Xiaoli Lan, Xiao Zhang, Mengting Li, Shujuan Liu, Fei Kang, Jing Wang
Surgical evidence-based comparison of [ 68 Ga]Ga-FAPI-04 PET and MRI-DWI for assisting debulking surgery in ovarian cancer patients. European journal of nuclear medicine and molecular imaging 51 (6) (2024)
Xiang Li, Xiaohui Lv, Zhiyong Quan, Tingting Han, Yongqiang Tang, Ying Liu, Mengxin Wang, Guiyu Li, Jiajun Ye, Jingyi Wang, Xiaoli Lan, Xiao Zhang, Mengting Li, Shujuan Liu, Fei Kang, Jing Wang
Surgical evidence-based comparison of [ 68 Ga]Ga-FAPI-04 PET and MRI-DWI for assisting debulking surgery in ovarian cancer patients. European journal of nuclear medicine and molecular imaging 51 (6) (2024)
Mingru Zhang, Fei Kang, Tong Xing, Junling Wang, Taoqi Ma, Guiyu Li, Zhiyong Quan, Weidong Yang, Xiaoyuan Chen, Jing Wang
First-in-human validation of enzymolysis clearance strategy for decreasing renal radioactivity using modified [ 68 Ga]Ga-HER2 Affibody. European journal of nuclear medicine and molecular imaging 51 (6) (2024)
Xiang Li, Xiaohui Lv, Zhiyong Quan, Tingting Han, Yongqiang Tang, Ying Liu, Mengxin Wang, Guiyu Li, Jiajun Ye, Jingyi Wang, Xiaoli Lan, Xiao Zhang, Mengting Li, Shujuan Liu, Fei Kang, Jing Wang
Surgical evidence-based comparison of [ 68 Ga]Ga-FAPI-04 PET and MRI-DWI for assisting debulking surgery in ovarian cancer patients. European journal of nuclear medicine and molecular imaging (2024)
Mingru Zhang, Fei Kang, Tong Xing, Junling Wang, Taoqi Ma, Guiyu Li, Zhiyong Quan, Weidong Yang, Xiaoyuan Chen, Jing Wang
First-in-human validation of enzymolysis clearance strategy for decreasing renal radioactivity using modified [ 68 Ga]Ga-HER2 Affibody. European journal of nuclear medicine and molecular imaging 51 (6) (2024)
Jiajun Ye, Weidong Yang, Zhaojuan Xie, Yuhao Yan, Guoquan Li, Guiyu Li, Xiang Li, Wenhui Ma, Fei Kang, Mingru Zhang, Jing Wang
Safety, Biodistribution, and Dosimetry Study of Meplazumab, a Potential COVID-19 Therapeutic Drug, with 131 I-Labeling and SPECT Imaging. Molecular pharmaceutics (2023)
Jiajun Ye, Weidong Yang, Zhaojuan Xie, Yuhao Yan, Guoquan Li, Guiyu Li, Xiang Li, Wenhui Ma, Fei Kang, Mingru Zhang, Jing Wang
Safety, Biodistribution, and Dosimetry Study of Meplazumab, a Potential COVID-19 Therapeutic Drug, with 131 I-Labeling and SPECT Imaging. Molecular pharmaceutics (2023)
Jiajun Ye, Weidong Yang, Zhaojuan Xie, Yuhao Yan, Guoquan Li, Guiyu Li, Xiang Li, Wenhui Ma, Fei Kang, Mingru Zhang, Jing Wang
Safety, Biodistribution, and Dosimetry Study of Meplazumab, a Potential COVID-19 Therapeutic Drug, with 131 I-Labeling and SPECT Imaging. Molecular pharmaceutics 20 (3) (2023)
Jiajun Ye, Weidong Yang, Zhaojuan Xie, Yuhao Yan, Guoquan Li, Guiyu Li, Xiang Li, Wenhui Ma, Fei Kang, Mingru Zhang, Jing Wang
Safety, Biodistribution, and Dosimetry Study of Meplazumab, a Potential COVID-19 Therapeutic Drug, with 131 I-Labeling and SPECT Imaging. Molecular pharmaceutics 20 (3) (2023)
Qing Ruan, Cheng Zhou, Qianna Wang, Fei Kang, Yuhao Jiang, Guoquan Li, Junhong Feng, Shu Zong, Junbo Zhang, Jing Wang
A Simple Kit Formulation for Preparation and Exploratory Human Studies of a Novel 99m Tc-Labeled Fibroblast Activation Protein Inhibitor Tracer for Imaging of the Fibroblast Activation Protein in Cancers. Molecular pharmaceutics (2023)
Qing Ruan, Cheng Zhou, Qianna Wang, Fei Kang, Yuhao Jiang, Guoquan Li, Junhong Feng, Shu Zong, Junbo Zhang, Jing Wang
A Simple Kit Formulation for Preparation and Exploratory Human Studies of a Novel 99m Tc-Labeled Fibroblast Activation Protein Inhibitor Tracer for Imaging of the Fibroblast Activation Protein in Cancers. Molecular pharmaceutics (2023)
Qing Ruan, Cheng Zhou, Qianna Wang, Fei Kang, Yuhao Jiang, Guoquan Li, Junhong Feng, Shu Zong, Junbo Zhang, Jing Wang
A Simple Kit Formulation for Preparation and Exploratory Human Studies of a Novel 99m Tc-Labeled Fibroblast Activation Protein Inhibitor Tracer for Imaging of the Fibroblast Activation Protein in Cancers. Molecular pharmaceutics (2023)
Qing Ruan, Cheng Zhou, Qianna Wang, Fei Kang, Yuhao Jiang, Guoquan Li, Junhong Feng, Shu Zong, Junbo Zhang, Jing Wang
A Simple Kit Formulation for Preparation and Exploratory Human Studies of a Novel 99m Tc-Labeled Fibroblast Activation Protein Inhibitor Tracer for Imaging of the Fibroblast Activation Protein in Cancers. Molecular pharmaceutics (2023)
Jiajun Ye, Weidong Yang, Zhaojuan Xie, Yuhao Yan, Guoquan Li, Guiyu Li, Xiang Li, Wenhui Ma, Fei Kang, Mingru Zhang, Jing Wang
Safety, Biodistribution, and Dosimetry Study of Meplazumab, a Potential COVID-19 Therapeutic Drug, with 131 I-Labeling and SPECT Imaging. Molecular pharmaceutics 20 (3) (2023)
Jiajun Ye, Weidong Yang, Zhaojuan Xie, Yuhao Yan, Guoquan Li, Guiyu Li, Xiang Li, Wenhui Ma, Fei Kang, Mingru Zhang, Jing Wang
Safety, Biodistribution, and Dosimetry Study of Meplazumab, a Potential COVID-19 Therapeutic Drug, with 131 I-Labeling and SPECT Imaging. Molecular pharmaceutics (2023)
Zhe Zhang, Xiaobo Wang, Jiajun Ye, Huanhuan Liu, Jianyang Fang, Mingru Zhang, Yesen Li, Jinxiong Huang, Deliang Zhang, Jing Wang, Xianzhong Zhang
Development and Preclinical Evaluation of Radiolabeled Covalent G12C-Specific Inhibitors for Direct Imaging of the Oncogenic KRAS Mutant. Molecular pharmaceutics 18 (9) (2021)
Fei Kang, Qing Han, Xiang Zhou, Zhaohui Zheng, Shengjun Wang, Wenhui Ma, Kui Zhang, Zhiyong Quan, Weidong Yang, Jing Wang, Ping Zhu
Performance of the PET vascular activity score (PETVAS) for qualitative and quantitative assessment of inflammatory activity in Takayasu's arteritis patients. European journal of nuclear medicine and molecular imaging 47 (13) (2020)
Fei Kang, Wei Mu, Jie Gong, Shengjun Wang, Guoquan Li, Guiyu Li, Wei Qin, Jie Tian, Jing Wang
Integrating manual diagnosis into radiomics for reducing the false positive rate of 18F-FDG PET/CT diagnosis in patients with suspected lung cancer. European journal of nuclear medicine and molecular imaging 46 (13) (2019)
Zhengjie Wang, Xiaolong Xu, Yi Liu, Yongheng Gao, Fei Kang, Bao-Hua Liu, Jing Wang
Assessment of the Aging of the Brown Adipose Tissue by 18F-FDG PET/CT Imaging in the Progeria Mouse Model Lmna-/. Contrast media & molecular imaging 2018 (2018)